Aussie Researchers Part Of Global Plan For Trials Of Lung-Cancer Drugs
This article was originally published in PharmAsia News
Australian scientists were part of international research that determined a genetic mutation blocked existing drugs for treating some of the toughest forms of cancer
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.